Zhang Y, Sun X, Huang M, Ke Y, Wang J, Liu X. Drug Des Devel Ther. 2015;9:29472959.

At the request of the authors, the Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding duplicated mouse images and cell staining images in Figures 4A and 5A, respectively. The authors were unable to locate the original data for their study and thus were unable to verify the validity of the data. To ensure the integrity of the publication record the authors requested to retract the paper and the editor has agreed with this decision.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as Retracted.

This retraction relates to this paper

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Original post:

Retraction for the article A novel bispecific immunotoxin delivered by | DDDT - Dove Medical Press

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh